about
GlycoMimetics Inc is a clinical-stage biotechnology company. It is focused on the discovery and development of novel glycomimetic drugs to address unmet medical needs resulting from diseases in which carbohydrate biology plays a key role. Glycomimeti...
Read More
16.89
0.12
(0.72%)
3.1M
XNAS Volume
High volume today
XNAS 18 Sep, 2026 5:30 PM (EDT)
Not Eligible
Expensive Valuation
Technically Moderately Bullish
GlycoMimetics Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..